IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Feb 2004 (Vol: 2004, Issue: 44)

Next Issue >>

Section: Company Profile
Intercell AG Published: 4 Feb-2004
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Shire’s Exit Strategy from Japan Provides Bayer with Exclusive Product Rights Published: 4 Feb-2004
By: Business Review Editor
Abstract Fulltext:
Section: Licensing
AstraZeneca and Array BioPharma Sign Oncology Agreement Published: 4 Feb-2004
By: Business Review Editor
Abstract Fulltext:
Amgen Licenses Stem Cell Growth Factors to ViaCell Published: 4 Feb-2004
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Abbott to Acquire Diagnostics Manufacturer for US$392 M Published: 4 Feb-2004
By: Business Review Editor
Abstract Fulltext:
CSL Combines with Aventis to Create ZLB Behring Published: 4 Feb-2004
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
GlaxoSmithKline and NeuroSearch to Investigate CNS Diseases Published: 4 Feb-2004
By: Business Review Editor
Abstract Fulltext:

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

Login

Username:

Password:

Keep me logged in